Chen, Lijuan et al. published their patent in 2020 |CAS: 66855-92-3

The Article related to carboline derivative analog preparation antitumor drug, Heterocyclic Compounds (More Than One Hetero Atom): Fused-Ring Systems With Two Or More Hetero Atoms, No More Than One Hetero Atom Per Ring and other aspects.SDS of cas: 66855-92-3

On June 26, 2020, Chen, Lijuan; Li, Yong; Yang, Jianhong published a patent.SDS of cas: 66855-92-3 The title of the patent was Carboline derivative/analogue, its preparation method and application in antitumor drug preparation. And the patent contained the following:

The title carboline derivative/analog is compound I with structural formula shown in claim 1 or its pharmaceutically acceptable salt, wherein X1 and X2 are N or CH, Y is CH2 or NR3, Z is NH, CH2 or O, R1 and R3 are H or C1-3 alkyl, and R2 is C1-6 alkyl, C2-6 alkenyl, etc. The carboline derivative/analog has antitumor activity, and can be used to prepare antitumor drug for breast cancer, cervical cancer, etc., and microtubule inhibitor (microtubule protein degradation agent). The experimental process involved the reaction of 3-(2-Methoxyphenoxy)benzaldehyde(cas: 66855-92-3).SDS of cas: 66855-92-3

The Article related to carboline derivative analog preparation antitumor drug, Heterocyclic Compounds (More Than One Hetero Atom): Fused-Ring Systems With Two Or More Hetero Atoms, No More Than One Hetero Atom Per Ring and other aspects.SDS of cas: 66855-92-3

Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem